SCHEMBL4475939

SCHEMBL4475939

C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(Oc3ccccc3)c2)cc1)N(C[C@H](O)c1cccnc1)C(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 19/20 0.53
ADRB1 P08588 13/20 0.53
PSMB5 P28074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4463379 0.85 ADRB3 (0.51) ADRB3ADRB1
SCHEMBL4462089 0.85 ADRB3 (0.59) ADRB3ADRB1
Hydrochloric Acid SCHEMBL4478367 0.79 ADRB3 (0.79) ADRB3ADRB1
Hydrochloric Acid SCHEMBL4478370 0.79 ADRB3 (0.79) ADRB3ADRB1
SCHEMBL1620795 0.76 ADRB3 (0.64) ADRB3ADRB1
SCHEMBL1620798 0.76 ADRB3 (0.64) ADRB3ADRB1
SCHEMBL4583928 0.76 ADRB3 (0.53) ADRB3ADRB1
SCHEMBL4583920 0.76 ADRB3 (0.53) ADRB3ADRB1
SCHEMBL4584667 0.74 ADRB3 (0.63) ADRB3ADRB1
SCHEMBL4584662 0.74 ADRB3 (0.63) ADRB3ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629366-B2 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2009-12-08 US disclosed
US-20060100252-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2006-05-11 US disclosed
US-7037938-B2 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2006-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100252-A1 Aminoalcohol derivatives H1-0, CHRM2, CHRM1 ADRB3 130/4885ADRB1 39/4885PSMB5 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.